Related Experiment Video

Updated: May 31, 2025

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

8.9K

Diagnostic Approach to Pneumonia in Immunocompromised Hosts

Nadir Ullah1, Ludovica Fusco2,3, Luigi Ametrano2,3

  • 1Department of Health Sciences (DISSAL), University of Genoa, 16126 Genoa, Italy.

Journal of Clinical Medicine
|January 25, 2025
PubMed

Insights

Diagnosing pneumonia in immunocompromised patients is challenging. This review covers current and future microbiological diagnostic techniques, including molecular methods and metagenomics, for accurate pathogen detection.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Pneumonia in immunocompromised patients poses diagnostic challenges due to varied causes, non-specific symptoms, and rapid progression.
  • Accurate and timely identification of all pathogens is essential for effective treatment.

Purpose of the Study:

  • To review the latest advancements in microbiological diagnostic techniques for pneumonia in immunocompromised individuals.
  • To cover a broad spectrum of pathogens, including bacterial, viral, fungal, and parasitic causes.

Main Methods:

  • Narrative review of current and emerging diagnostic tools.
  • Discussion of traditional culture methods, antigen tests, molecular diagnostics, and microscopy.
  • Exploration of future technologies like metagenomics and CRISPR/Cas13a.

Main Results:

  • Traditional cultures are vital but have limitations in speed and sensitivity.
  • Non-invasive antigen tests and molecular diagnostics offer more efficient detection, particularly for viral and fungal infections.
  • Metagenomics and CRISPR/Cas13a show promise for precise and rapid pathogen identification.

Conclusions:

  • A combination of diagnostic methods is often necessary for comprehensive pathogen detection.
  • Advancements in molecular and genomic technologies are improving pneumonia diagnostics in immunocompromised populations.
  • Future diagnostics aim for greater speed, precision, and breadth in pathogen identification.
Keywords:
antigenic testscultureimmunocompromised patientsmicrobiological diagnosispneumoniapolymerase chain reaction

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

359

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
211
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K